HUB NEWS
Original HUB News abstract news illustration; not a photograph of the event.
HUB NEWS SUMMARY · News

Stanford review links metformin use to lower post-COVID death risk

Reporting by Fox News ·

A Stanford-led analysis of U.S. medical records found adults with type 2 diabetes who took metformin before testing positive for COVID-19 had a 39% lower risk of dying within a year than those on DPP-4 inhibitors.

This is HUB News’s original summary. Read the complete report at Fox News.